Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Dengue Swells As US Vaccine Prospects Recede

Jul 02 2024

• By Bridget Silverman

dengue vaccine — The US now has no approved dengue vaccines available. • Source: Shutterstock

Related Content

Dengvaxia Dengue Vaccine Finally Gets Green Light From CDC’s Advisory Committee

Jun 25 2021

Dengvaxia’s Restrictive Indication Will Make Immunization Recommendations Difficult, ACIP Members Say

Jul 02 2019

Sanofi's Dengvaxia: ACIP Decision On Use Will Hinge On Screening Test

Oct 28 2019

Early Strides for Takeda’s Qdenga In Brazil, India Deal Adds New Dimension

Mar 18 2024

Priority Review Vouchers: Tropical Disease Candidates Wait Years For FDA Action On Qualifying List

Apr 26 2024

Takeda Pulls US BLA For Dengue Vaccine

Jul 12 2023

Related Companies

Sanofi

Takeda Pharmaceutical Co. Ltd.

Merck & Co., Inc.

Additional Topics

United States Vaccines Regulation Infectious Diseases BioPharmaceutical

More from Vaccines

More from Pink Sheet

Twitter feed RSS feed RSS feed

About Us

Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us

Customer Service
SubscribeOpens in new window
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window

Copyright © 2025 Pharma Intelligence UK Limited (Citeline), a Norstella company Pharma Intelligence UK Limited is a company registered in England and Wales with company number 13787459 whose registered.